C-MOP Consent Form

1.  I understand that Meakin Metabolic Care (MMC) is a virtual platform that is striving to lower the financial burden and inefficiencies of a typical medical practice to bring fellow Americans the best services to better their health.
   
   
2. I understand that the virtual platform does not allow for standard physical exams and other onsite procedures and inquiries that enhance findings and insights. I, therefore, understand I need to maintain a local physician and possible oncologist if appropriate to support my care.
   
   
3. I understand that the fees charged for these services are not covered by Medicare, Medicaid, or other insurance and MMC does not submit information for insurance approvals or referrals.
   
   
4. I understand that MMC strives to be efficient to lower the cost to their patients and therefore scheduling and interactions are done through the patient portal and website.
   
   
5. In keeping with our mission, MMC is uniquely mindful of the overwhelming nature of certain diagnoses and associated costs and has opportunities upon request to lower or eliminate fees.
   
   
6. I understand that metabolic management for disease prevention and cancer care enhancement is an evolving pattern of care and randomized trials for supplements and repurposed drugs used off-label are rarely available.
   
   
7. I understand MMC will offer customized pharmaceutical and supplement options and use laboratory values and known algorithms to optimize safety.
   
   
8. I understand it is my responsibility to submit the needed medical information to the portal and offer feedback at the evaluations to best enable MMC to offer safe care.
   
   
9. I understand that MMC is not set up to call and communicate with other physicians on a routine basis and it is the patient responsibility to review with their other physicians the care program offered by MMC and the associated medications and supplements.
   
   
10. I understand MMC will use best practices with lifestyle modifications applied to best tolerance to also support my course.
    
    
11. I understand I am not obligated to continue the care after initiation, and I proceed by my own choice.
    
    
12. I understand I can terminate this relationship at any time and MMC can terminate at any time as well.
    
    
13. I understand the challenging nature of virtual care and therefore will be understanding if electronics or Wi-Fi impact the schedule and be mindful of the time windows in the scheduling to best enable MMC to stay on track for other patients as well.
    
    
14. I understand the goals and purpose of MMC in the support of my health goals and am ready to proceed and consent to the evaluation and discussion of therapies using this format.

Nature and Scope of the Treatment Plan

The treatment plan is designed to complement, not replace, conventional oncology treatments such as chemotherapy, radiation, and surgery. It includes dietary guidelines, natural product supplements, and re-purposed off-label pharmaceuticals. These recommendations are based on evidence from in-vitro and in-vivo studies, as well as limited human clinical trials. The plan is not considered standard-of-care by conventional medical oncology specialties in the USA or Canada. It aims to integrate findings from molecular biology and cancer research to provide additional therapeutic options.

Goals and Expectations

The primary goals of the treatment plan are to:

• Increase control over cancer progression by reducing, stopping, or decreasing the amount of cancer, and maintaining this control for as long as possible.
• Significantly improves the quality of life compared to similar patients receiving only conventional treatments.
• Significantly increases the length of life compared to similar patients receiving only conventional treatments.

It is explicitly stated that this treatment plan used alone is not a cure for cancer and should not be considered as such. The potential benefits are not guaranteed, and the effectiveness of the treatment plan cannot be confirmed due to the lack of comprehensive clinical trial data.

Risks and Informed Consent

The consent form emphasizes that there are some unknown, unforeseen, and unpredictable risks associated with the treatment plan, including serious illness and possibly death. Patients are informed that conventional oncology treatments have documented risks, whereas this integrative plan does not have specific data on all possible adverse effects. Patients must acknowledge and accept these risks to proceed with the treatment.

Risk management involves immediate cessation of the treatment plan if any adverse effects are noticed, with the requirement to document and report these effects to the overseeing care manager, nurse who will alert the physician. Ongoing documentation through daily checklists and journals is encouraged to monitor progress and manage any adverse effects. Patients are encouraged to ask questions and can contact their care manager or nurse at any time for further information.

In summary, this consent form outlines a complementary treatment plan that integrates conventional oncology with additional molecular integrative options, sets realistic goals for improving quality and length of life, and requires informed consent due to the potential risks and lack of comprehensive clinical trial data.